GET DAILY SIGNALSTurning Point Brands (TPB) Reports +27% Revenue Growth in Q3 as Modern Oral Category Expands
Key Takeaways
- Total net sales rose 27.0% year over year to $151.1 million, driven by triple-digit growth in the Modern Oral nicotine pouch category.
- Net income fell 81.4% to $3.9 million, while adjusted EBITDA declined 41.3% to $18.4 million as sales and marketing investment climbed.
- GAAP diluted EPS was $0.19, down from $1.13 a year earlier; adjusted diluted EPS was $0.41, beating consensus expectations.
- Modern Oral net sales more than doubled to $74.4 million and now represent roughly 49% of total company sales, up from 31% a year ago.
- Management reaffirmed its full-year 2026 outlook for Modern Oral gross sales of $330–$350 million and adjusted EBITDA of $70–$80 million.
Earnings Context and Why It Matters
Turning Point Brands is navigating a strategic shift, channeling cash flow from its established Zig-Zag and Stoker's operations into the rapidly expanding nicotine pouch segment via its FRE and ALP brands. This transition is producing strong top-line expansion while pressuring near-term profitability due to elevated spending on distribution and marketing. In my view, the report provides a useful test of whether investors will accept softer current earnings in pursuit of longer-term market position. With Modern Oral now nearing half of overall sales, the quarter gives a clear snapshot of how effectively the company can turn distribution gains and consumer interest into sustained, higher-margin revenue.
Reported Results
Turning Point Brands posted third quarter 2026 net sales of $151.1 million, up 27.0% from $119.0 million a year earlier and ahead of consensus revenue estimates near $146.7 million. Gross profit rose 20.9% to $85.2 million. Net income attributable to the company dropped 81.4% to $3.9 million, and diluted EPS fell to $0.19 from $1.13 in the prior-year quarter. Adjusted diluted EPS reached $0.41, surpassing analyst consensus, while adjusted EBITDA decreased 41.3% to $18.4 million.
The profitability shortfall stems from a 69.1% jump in SG&A expenses to $75.3 million, reflecting heavier Modern Oral sales and marketing outlays plus higher outbound freight costs. By segment, Stoker's net sales increased 52.0% to $113.8 million on Modern Oral momentum, whereas Zig-Zag net sales declined 15.5% to $37.3 million. The company closed the quarter with $251.3 million in cash and bought back $10.0 million of stock. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Market Reaction and Investor Sentiment
Even with the revenue beat and adjusted EPS upside, the stock moved lower after the release, as investors focused on the steep drop in adjusted EBITDA and the ongoing costs of scaling the nicotine pouch business. The market balanced strong top-line results against narrower margins, the broad full-year EBITDA guidance range, and slower sequential Modern Oral growth relative to prior quarters. Sentiment before and after the announcement centered on whether the company can achieve operating leverage as its distribution network matures.
Forward Outlook and Key Factors to Monitor
Management reaffirmed its full-year 2026 guidance, including Modern Oral gross sales of $330–$350 million, Modern Oral net sales of $260–$270 million, and adjusted EBITDA of $70–$80 million. The implied fourth-quarter Modern Oral net sales range points to roughly flat to modestly higher sequential performance, so investors will monitor whether additional chain placements and spring shelf resets can accelerate revenue into 2027.
Cost discipline remains a key focus. The company noted it trimmed marketing programs with weaker returns during the quarter, and its success in shifting spending toward higher-return efforts will shape margin improvement. On the supply side, U.S. manufacturing in Louisville is now slated to start in 2027, subject to FDA timing and PMTA approvals. Management indicated it is preparing a second PMTA submission to enable domestic production without interrupting the existing application.
Additional items to watch include the path of the Zig-Zag business, which continues to provide steady but slower cash flow, and capital allocation given the $251 million cash position and measured buyback activity. Regulatory developments, distribution progress with FRE and ALP, and the pace of operating leverage will likely be important variables in coming quarters.
Using AI Tools in My Research
When analyzing consumer-sector names like this one, I find Tickeron’s AI Screener helpful for quickly filtering stocks by industry, fundamentals, and technical signals. It lets me compare opportunities across the market and track momentum shifts without spending hours on manual reviews, which keeps my process efficient while staying focused on the data that matters most.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
TPB's RSI Indicator ascending out of oversold territory
The RSI Oscillator for TPB moved out of oversold territory on October 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 25 of the 31 cases the stock moved higher. This puts the odds of a move higher at 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on TPB as a result. In 55 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for TPB just turned positive on October 07, 2026. Looking at past instances where TPB's MACD turned positive, the stock continued to rise in 28 of 40 cases over the following month. The odds of a continued upward trend are 70%.
TPB moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for TPB crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 59%.
Following a +5.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where TPB advanced for three days, in 231 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 56 cases where TPB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TPB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
TPB broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TPB entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. TPB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.071) is normal, around the industry mean (-7.297). P/E Ratio (28.154) is within average values for comparable stocks, (12.512). Projected Growth (PEG Ratio) (0.048) is also within normal values, averaging (3.595). Dividend Yield (0.005) settles around the average of (0.060) among similar stocks. P/S Ratio (2.701) is also within normal values, averaging (2.780).
The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TPB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of tobacco products
Industry Tobacco
Advertisement